Similar articles for PMID: 21502077

Year	Number of Results
2006	2
2007	2
2009	2
2011	4
2012	5
2013	9
2014	11
2015	13
2016	8
2017	9
2018	14
2019	17
2020	18
2021	36
2022	124
2023	53
2024	2

1

A review of the current scientific and regulatory status of nanomedicines and the challenges ahead.

Hock SC, Ying YM, Wah CL. Hock SC, et al. PDA J Pharm Sci Technol. 2011 Mar-Apr;65(2):177-95. PDA J Pharm Sci Technol. 2011. PMID: 21502077 Review.

2

Updated Regulatory Considerations for Nanomedicines.

Subin TS, Vijayan V, Kumar KJR. Subin TS, et al. Pharm Nanotechnol. 2017;5(3):180-191. doi: 10.2174/2211738505666170615095542. Pharm Nanotechnol. 2017. PMID: 28641516 Review.

3

Advances and challenges in nanocarriers and nanomedicines for veterinary application.

Carvalho SG, Araujo VHS, Dos Santos AM, Duarte JL, Silvestre ALP, Fonseca-Santos B, Villanova JCO, Gremião MPD, Chorilli M. Carvalho SG, et al. Int J Pharm. 2020 Apr 30;580:119214. doi: 10.1016/j.ijpharm.2020.119214. Epub 2020 Mar 9. Int J Pharm. 2020. PMID: 32165220 Free article. Review.

4

Safety and Toxicological Considerations of Nanomedicines: The Future Directions.

Patel P, Shah J. Patel P, et al. Curr Clin Pharmacol. 2017;12(2):73-82. doi: 10.2174/1574884712666170509161252. Curr Clin Pharmacol. 2017. PMID: 28486906 Review.

5

Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.

Gioria S, Caputo F, Urbán P, Maguire CM, Bremer-Hoffmann S, Prina-Mello A, Calzolai L, Mehn D. Gioria S, et al. Nanomedicine (Lond). 2018 Mar 1;13(5):539-554. doi: 10.2217/nnm-2017-0338. Epub 2018 Jan 30. Nanomedicine (Lond). 2018. PMID: 29381129 Free article.

6

Nanotechnology versus other techniques in improving drug dissolution.

Kwok PC, Chan HK. Kwok PC, et al. Curr Pharm Des. 2014;20(3):474-82. doi: 10.2174/13816128113199990400. Curr Pharm Des. 2014. PMID: 23651399 Free article. Review.

7

Nanomedicines accessible in the market for clinical interventions.

Gadekar V, Borade Y, Kannaujia S, Rajpoot K, Anup N, Tambe V, Kalia K, Tekade RK. Gadekar V, et al. J Control Release. 2021 Feb 10;330:372-397. doi: 10.1016/j.jconrel.2020.12.034. Epub 2020 Dec 25. J Control Release. 2021. PMID: 33370576 Review.

8

Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.

Lembo D, Donalisio M, Civra A, Argenziano M, Cavalli R. Lembo D, et al. Expert Opin Drug Deliv. 2018 Jan;15(1):93-114. doi: 10.1080/17425247.2017.1360863. Epub 2017 Aug 3. Expert Opin Drug Deliv. 2018. PMID: 28749739 Free article.

9

Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.

Teja PK, Mithiya J, Kate AS, Bairwa K, Chauthe SK. Teja PK, et al. Phytomedicine. 2022 Feb;96:153890. doi: 10.1016/j.phymed.2021.153890. Epub 2021 Dec 17. Phytomedicine. 2022. PMID: 35026510 Review.

10

Systematic Patent Review of Nanoparticles in Drug Delivery and Cancer Therapy in the Last Decade.

Ali Hazis NU, Aneja N, Rajabalaya R, David SR. Ali Hazis NU, et al. Recent Adv Drug Deliv Formul. 2021;15(1):59-74. doi: 10.2174/1872211314666210521105534. Recent Adv Drug Deliv Formul. 2021. PMID: 34602031 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

286 results

Results by year